chartexchange

Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences

GlobeNewswire Inc. | Oct 19, 2026 8:00 AM EDT

MONTREAL and CHARLOTTE, N.C., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that data and program updates for CARDAMYST® (etripamil) nasal spray for its approved PSVT indication and on etripamil nasal spray for an investigational indication will be presented at three upcoming cardiovascular medical meetings:

Read original article